Your browser doesn't support javascript.
loading
The TB vaccine development pathway - An innovative approach to accelerating global TB vaccine development.
Roordink, Danielle; Williams, Ann; Fritzell, Bernard; Laddy, Dominick J; Gerdil, Emmanuelle; Graffin, Anne Marie; Tait, Dereck; van der Pol, Leo; van den Brink, Ilona; Holleman, Marit; Thole, Jelle; Voss, Gerald; Lempicki, Maria; Thiry, Georges.
Afiliação
  • Roordink D; TuBerculosis Vaccine Initiative (TBVI), Lelystad, the Netherlands. Electronic address: Danielle.roordink@tbvi.eu.
  • Williams A; TuBerculosis Vaccine Initiative (TBVI), Lelystad, the Netherlands.
  • Fritzell B; TuBerculosis Vaccine Initiative (TBVI), Lelystad, the Netherlands.
  • Laddy DJ; IAVI, New York, USA.
  • Gerdil E; TuBerculosis Vaccine Initiative (TBVI), Lelystad, the Netherlands.
  • Graffin AM; TuBerculosis Vaccine Initiative (TBVI), Lelystad, the Netherlands.
  • Tait D; IAVI, Cape Town, South Africa.
  • van der Pol L; TuBerculosis Vaccine Initiative (TBVI), Lelystad, the Netherlands.
  • van den Brink I; TuBerculosis Vaccine Initiative (TBVI), Lelystad, the Netherlands.
  • Holleman M; TuBerculosis Vaccine Initiative (TBVI), Lelystad, the Netherlands.
  • Thole J; TuBerculosis Vaccine Initiative (TBVI), Lelystad, the Netherlands.
  • Voss G; TuBerculosis Vaccine Initiative (TBVI), Lelystad, the Netherlands.
  • Lempicki M; IAVI, New York, USA.
  • Thiry G; TuBerculosis Vaccine Initiative (TBVI), Lelystad, the Netherlands.
Tuberculosis (Edinb) ; 126: 102040, 2021 01.
Article em En | MEDLINE | ID: mdl-33310626

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Tuberculose / Imunização Secundária / Vacinas contra a Tuberculose / Desenvolvimento de Medicamentos / Mycobacterium tuberculosis Tipo de estudo: Guideline / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Tuberculose / Imunização Secundária / Vacinas contra a Tuberculose / Desenvolvimento de Medicamentos / Mycobacterium tuberculosis Tipo de estudo: Guideline / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Ano de publicação: 2021 Tipo de documento: Article